InsiderTrades

Form 4 for DRMA Dermata Therapeutics, Inc.

Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-16 · accession 0000905718-21-001094 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2021-08-17 2021-08-16+ DRMA PROEHL GERALD T Pres, CEO, COB, Dir, 10% P - Purchase $4.96 +152.9K 152.9K New +$758.2K
DMI 2021-08-17 2021-08-17 DRMA PROEHL GERALD T Pres, CEO, COB, Dir, 10% C - Cnv Deriv — +2.05M 1.28M New —
DMI 2021-08-17 2021-08-17 DRMA PROEHL GERALD T Pres, CEO, COB, Dir, 10% C - Cnv Deriv $0.00 -36.76M 0 -100% $0
DI 2021-08-17 2021-08-17 DRMA PROEHL GERALD T Pres, CEO, COB, Dir, 10% P - Purchase — +142.9K 142.9K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-16 P A 10,000 $4.96 10,000 I By Proehl Family Trust — — (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.84 to $5.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
2 Common Common Stock 2021-08-17 C A 17,857 — 17,857 I By Allison Taylor Proehl 2020 Irrevocable Trust — — (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
3 Common Common Stock 2021-08-17 C A 8,928 — 8,928 I By Meghan Proehl Wilder 2020 Irrevocable Trust — — (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
4 Common Common Stock 2021-08-17 C A 35,767 — 35,767 I By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 — — (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
5 Common Common Stock 2021-08-17 P A 142,857 — 152,857 I By Proehl Family Trust — — (F9) Reporting Person purchased 142,857 Units in the IPO at $7.00 per Unit Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
6 Common Common Stock 2021-08-17 C A 111,951 — 1,390,415 I By Proehl Investment Ventures LLC — — (F3) The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
7 Common Common Stock 2021-08-17 C A 181,585 — 1,572,000 I By Proehl Investment Ventures LLC — — (F4) The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
8 Common Common Stock 2021-08-17 C A 1,247,904 — 2,819,904 I By Proehl Investment Ventures LLC — — (F5) The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
9 Common Common Stock 2021-08-17 C A 85,640 — 2,905,544 I By Proehl Investment Ventures LLC — — (F6) The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
10 Common Common Stock 2021-08-17 C A 361,147 — 1,278,464 I By Proehl Investment Ventures LLC — — (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
11 Derivative Series 1 Preferred Stock 2021-08-17 C D 1,755,622 $0.00 0 I By Proehl Investment Ventures LLC — · — to — 85,640 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F6) The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
12 Derivative Series 1a Warrants 2021-08-17 C D 573,750 $0.00 0 I By Proehl Investment Ventures LLC — · 2016-11-15 to 2026-03-14 27,987 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F7) The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.
13 Derivative Warrant to Purchase Common Stock 2021-08-17 C A 27,987 $0.00 27,987 I By Proehl Investment Ventures LLC $20.50 · 2016-11-15 to 2026-03-14 27,987 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
14 Derivative Warrant to Purchase Common Stock 2021-08-17 P A 142,857 — 142,857 I By Proehl Family Trust $7.00 · 2021-08-17 to 2026-08-17 142,857 Common Stock (F9) Reporting Person purchased 142,857 Units in the IPO at $7.00 per Unit Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock. (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
15 Derivative Series 1d Preferred Stock 2021-08-17 C D 120,481 $0.00 0 I By Allison Taylor Proehl 2020 Irrevocable Trust — · — to — 17,857 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
16 Derivative Series 1c Preferred Stock 2021-08-17 C D 25,582,050 $0.00 0 I By Proehl Investment Ventures LLC — · — to — 1,247,904 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F5) The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
17 Derivative Series 1d Preferred Stock 2021-08-17 C D 241,325 $0.00 0 I By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 — · — to — 35,767 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
18 Derivative Series 1d Preferred Stock 2021-08-17 C D 2,436,657 $0.00 0 I By Proehl Investment Ventures LLC — · — to — 361,147 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
19 Derivative Series 1a Preferred Stock 2021-08-17 C D 2,295,000 $0.00 0 I By Proehl Investment Ventures LLC — · — to — 111,951 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F3) The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
20 Derivative Series 1b Preferred Stock 2021-08-17 C D 3,722,500 $0.00 0 I By Proehl Investment Ventures LLC — · — to — 181,585 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F4) The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
21 Derivative Series 1d Preferred Stock 2021-08-17 C D 60,240 $0.00 0 I By Meghan Proehl Wilder 2020 Irrevocable Trust — · — to — 8,928 Common Stock (F8) Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F2) The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.